According to a GlobalData report, global market value for cardiovascular devices will grow at a compound annual growth rate (CAGR) of 6% to $62 billion by 2025. Credit; symbiot/Sutterstock

The European Commission has initiated without warning an inspection at the facilities of a company specialising in medical devices for cardiovascular applications.

The surprise inspection of the unnamed company follows concerns that the firm has been abusing and breaching EU antitrust regulations, related to Article 102 of the Treaty on the Functioning of the European Union, prohibiting abuses of a dominant market position.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Neither the company nor location of the company has been named yet but it has been identified as a manufacturer of cardiovascular medical devices.

Commission officials, armed with the authority to conduct such investigations, were accompanied by counterparts from the national competition authority of the Member State where the inspection was carried out.

Surprise inspections such as this are one of the courses of action to cull suspected anti-competitive behaviour. Although it shouldn’t imply that the company under scrutiny is guilty as the process is designed to be impartial and fair – allowing the company in question to defend themselves if they have been involved in anticompetitive practices. The EU commission will also allow the suspected company to present their case in antitrust proceedings before any conclusion is met.

The industry will be following this case closely as the outcome could have a far-reaching impact on the medical device sector.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

According to a GlobalData report, global market value for cardiovascular devices will grow at a compound annual growth rate (CAGR) of 6% to $62 billion by 2025.